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Abstract
The parasitic small hive beetle (Aethina tumida) feeds on pollen, honey and brood of the European honey bee (Apis mellifera); 
establishment in North America and Australia has resulted in severe economic damage to the apiculture industry. We report 
potential for the “in-hive” use of a novel biopesticide that is toxic to this invasive beetle pest but harmless to honeybees. 
Constructs encoding the spider venom neurotoxin ω-hexatoxin-Hv1a (Hv1a) linked to the N- or C-terminus of snowdrop lectin 
(GNA) were used to produce recombinant Hv1a/GNA and GNA/Hv1a fusion proteins. Both were similarly toxic to beetles 
by injection (respective  LD50s 1.5 and 0.9 nmoles/g larvae), whereas no effects on adult honeybee survival were observed 
at injection doses of > 200 nmoles/g insect. When fed to A. tumida larvae, GNA/Hv1a was significantly more effective than 
Hv1a/GNA  (LC50s of 0.52 and 1.14 mg/ml diet, respectively), whereas both proteins were similarly toxic to adults. Results 
suggested that the reduced efficacy of Hv1a/GNA against larvae was attributable to differences in the susceptibility of the 
fusion proteins to cleavage by gut serine proteases. In laboratory assays, A. tumida larval survival was significantly reduced 
when brood, inoculated with eggs, was treated with GNA/Hv1a.
Keywords Small hive beetle (Aethina tumida) · European honeybee (Apis mellifera) · Fusion proteins · ω-hexatoxin-Hv1a · 
Snowdrop lectin (Galanthus nivalis agglutinin)
Key message
• The small hive beetle is a serious invasive pest of the 
European honeybee and represents a serious threat to 
apiculture.
• Current chemical control methods are limited due to their 
inherent toxicity towards honeybees.
• Here we report the potential use of a recombinant fusion 
protein, containing a spider venom neuropeptide linked 
to a plant “carrier” lectin, as an “in-hive” treatment for 
the control of small hive beetle larvae and adults which 
has no toxicity towards bees.
Introduction
The small hive beetle (Aethina tumida) is native to sub-Saha-
ran Africa where it is an occasional parasite and scavenger 
of African (Apis mellifera scutellata) and Cape (Apis mellif-
era capensis) honeybee colonies (Lundie 1940; Smith 1953; 
Roberts 1971; Elzen et al. 2000). Growth in the international 
trade of honeybees and hive products over the last two dec-
ades has resulted in the spread of A. tumida into several 
countries where its establishment has resulted in significant 
economic impacts upon the apiculture industry (Elzen et al. 
1999; Gillespie et al. 2003).
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The domesticated honeybee Apis mellifera, generally con-
sidered to be the most economically valuable crop pollinator 
worldwide (Klein et al. 2007), is less aggressive than its 
African counterpart and allows A. tumida adults and larvae 
to feed unhindered on pollen, honey and brood. Beetle inva-
sion causes honey to ferment, combs to be destroyed, and 
often the rapid structural collapse and abandonment of hives 
(Spiewok et al. 2007). A further possible threat to the Euro-
pean honeybee is presented by A. tumida acting as a vector 
for deformed wing virus and the bacterial causative agent 
of American foulbrood (Paenibacillus larvae), which is cur-
rently believed to be the most widespread and destructive 
disease of bee brood (Eyer et al. 2009; Schäfer et al. 2010). 
Although the effects of A. tumida have been particularly 
severe in North America and Australia, the pest has been 
detected across a wide range of countries, including Canada, 
Egypt, Mexico, Sudan, Hawaii, Philippines, Portugal and 
Italy. This invasive pest represents a serious threat to apicul-
ture as well as wild and feral bee populations, particularly 
in regions where climatic and soil conditions are conducive 
to establishment (Neumann et al. 2016). Current A. tumida 
chemical control measures used in America include in-hive 
(coumaphos containing CheckMite + StripsTM) and soil 
drench (permethrin) applications, although their inherent 
toxicity to bees makes effective treatment problematic, and 
none are currently authorized for use in Europe. Currently 
used mechanical control methods include a range of traps 
although their effectiveness is limited as no lure has yet been 
developed that is more attractive to A. tumida than honey-
bees (Neumann et al. 2016). Given the various issues and 
limitations of current management options for A. tumida, 
alternative control strategies that are compatible with inte-
grated pest management practices are urgently required.
This paper demonstrates that a recombinant fusion pro-
tein comprised of the spider venom neurotoxin Hv1a linked 
to the mannose binding snowdrop lectin (Galanthus nivalis 
agglutinin [GNA]) has potential utility as an in-hive biope-
sticide to control A. tumida. The 37-residue Hv1a peptide 
belongs to the ω-HXTX-1 family of cysteine knot toxins 
originally isolated from the venom of the Australian fun-
nel web spider (Hadronyche versuta) (Tedford et al. 2004a). 
Hv1a targets sites within the insect central nervous system 
by blocking voltage-gated calcium channels (Fletcher et al. 
1997; Tedford et al. 2004b; Chong et al. 2007) and has been 
shown to be toxic by injection into a range of invertebrates 
including species belonging to the orders Diptera, Orthop-
tera, Lepidoptera, Homoptera and Arachnida (Atkinson et al. 
1998; Bloomquist 2003; Tedford et al. 2004b; Mukherjee 
et al. 2006; Fitches et al. 2012; Bonning et al. 2014). By con-
trast, Hv1a is harmless to vertebrates (Fletcher et al. 1997; 
Chong et al. 2007) and surprisingly harmless to honeybees 
(Nakasu et al. 2014), making it an ideal candidate for use 
in the development of a biopesticide for the control of A. 
tumida. Whilst toxic by injection, Hv1a, like many arach-
nid venom neurotoxins, is typically far less effective when 
delivered orally to insects (Fletcher et al. 1997). However, 
delivery to the haemolymph via leaky septate junctions 
in the midgut epithelium is thought to confer a degree of 
oral potency in certain species such as the dipteran species 
Lucilia cuprina and Drosophila melanogaster (Herzig et al. 
2014; Guo et al. 2018). We have previously demonstrated 
that linkage of Hv1a to GNA greatly enhances the oral effi-
cacy of the neurotoxin by virtue of the stability of GNA to 
gut proteolysis, and its ability to cross the gut epithelium and 
deliver Hv1a to the circulatory system, in larvae of the Lepi-
dopteran Mamestra brassicae (Fitches et al. 2012). Fusion 
to GNA has similarly been used to enhance oral efficacy of 
the venom toxins SFI1 (Segestria florentina toxin 1), PI1a 
(δ-Amaurobitoxin from Pireneitega luctuosus) and ButaIT 
(Red Scorpion toxin from Buthus tamulus) towards a range 
of insects (Fitches et al. 2004, 2010; Yang et al. 2014; Trung 
et al. 2006). Analogously, a luteovirus coat protein has been 
successfully used as a carrier to greatly enhance the oral 
toxicity of Hv1a to a range of aphid pest species (Bonning 
et al. 2014).
Bioassays of injection and oral toxicity of recombinant 
Hv1a, GNA and two Hv1a and GNA containing fusion pro-
teins towards A. tumida larvae and adults are reported. Dif-
ferences in oral toxicity of the fusion proteins are examined 
in relation to susceptibility to cleavage by beetle gut pro-
teases. Survival of A. tumida larvae reared on brood sprayed 
with fusion protein is reported, and injection studies pro-
vide further evidence of the inability of Hv1a to target ion 
channels in adult honeybees. These results demonstrate the 
potential of fusion proteins containing Hv1a and GNA as 
specific biopesticides to control A. tumida.
Materials and methods
Insect cultures
Aethina tumida cultures were maintained in darkness at 
20 °C, with 65% relative humidity (RH), in the Quarantine 
Entomology Unit (Fera Science Ltd.). The culture was orig-
inally established from wandering larvae imported under 
three levels of containment supplied by the Plant Protec-
tion Research Institute, South Africa. Mamestra brassicae 
(cabbage looper) originally obtained from cultures held 
at Fera Science Ltd. and were reared at the University of 
Durham continuously on artificial diet (Fitches et al. 2012) 
at 22–25 °C; 65% RH under a 16 h:8 h light:dark regime. 
Honeybee (Apis mellifera) adults and pupae were supplied 
by Fera Science Ltd. Home Apiary was maintained at 34 °C, 
65% RH, under darkness during bioassays.
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Recombinant protein production
Constructs encoding for the expression of GNA, GNA/Hv1a 
and Hv1a/GNA, depicted in Fig. 1a, were generated using 
previously generated plasmid DNA [Hv1a/GNA accession 
number JQ8980150 (Fitches et al. 2012)] using conventional 
PCR, restriction and ligation methods. All constructs include 
a six-residue histidine tag to enable affinity purification and 
detection by immunoassay. For Hv1a, a codon-optimized 
sequence including the predicted 17 residue pro-region 
(based on Omega-hexatoxin-Ar1d sequence UniprotKB: 
Accession No. A5A3H3) synthesized by ShinGene Molec-
ular Biotech, Inc. was used as the basis for the generation 
of the Hv1a expression construct that was cloned into the 
expression vector pGAPαB in frame with a C-terminal myc 
epitope and histidine tag. Sequence-verified clones in the 
shuttle vector pGAPZαB were transformed into chemically 
competent Pichia pastoris cells (strain SMD1168H or X33 
for GNA) according to Invitrogen protocols. Transformants, 
selected by plating on zeocin-containing medium (100 µg/
ml), were screened for expression in small-scale cultures by 
Western blotting (using anti-GNA and/or anti-His antibod-
ies) as described previously (Fitches et al. 2012).
For protein production, P. pastoris cells expressing 
recombinant proteins were grown in an Applikon ez-
Control laboratory fermenter (7.5 L vessel) as described 
previously (Fitches et al. 2012). Secreted proteins were 
separated from cells by centrifugation (30 min at 7500 g, 
4 °C) and clarified by vacuum filtration through 2.7 and 
0.7 µM glass fibre filters (Whatman). Recombinant pro-
teins were purified from supernatants by nickel affinity 
chromatography, dialysed and freeze-dried as described 
previously (Yang et al. 2014). Protein contents in lyo-
philized samples were determined from SDS-PAGE gels 
stained for total proteins with coomassie blue. Quantita-
tion was based on bands corresponding to intact proteins, 
which were compared to GNA (Sigma) standards by visual 
inspection, and by capturing an image of the destained gel 
using a commercial flat-bed scanner; image analysis was 
carried out with a custom-written software programme 
(ProQuantify supplied by Rodrigo Guerrero). For Hv1a, 
which does not resolve well on SDS-PAGE, protein con-
centrations were determined by BCA assay, using BSA as 
a standard protein.
(a)
(b) (c)
Fig. 1  a Schematic of constructs encoding recombinant proteins pro-
duced in the yeast P. pastoris showing predicted molecular masses 
including tri-alanine linkers. The α-factor pre-pro-sequence directs 
expressed protein to the yeast secretory pathway enabling purification 
from fermented culture supernatants. Tag denotes the presence of a 
six-residue histidine sequence that allows recombinant protein puri-
fication by nickel affinity chromatography. b Separation of purified 
recombinant proteins by SDS-PAGE gels stained for total protein: 
left, lane 1 Hv1a/GNA, lane 2 GNA/Hv1a, lane 3 GNA and lane 4 
Sigma GNA standard, right,  lanes 1 and 2 Hv1a, c western analysis 
of recombinant proteins using anti-GNA and anti-His antibodies, 
approx. 300 ng total protein loaded in all lanes. Location of protein 
mass markers run on the same gel are depicted
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Characterization of recombinant proteins
Proteins were routinely analysed by SDS-PAGE (17.5% 
acrylamide gels) and western blotting as described previ-
ously (Fitches et al. 2012). For the separation of Hv1a 
polypeptides, SDS-PAGE was carried out at 4 °C using a 
Tris-Tricine buffer system [15% and 4% (v/v) acrylamide 
separation and stacking gel, respectively] and gels were 
run at 100 V.
For N-terminal sequencing, Hv1a/GNA and Hv1a pro-
teins were separated by SDS-PAGE and transferred to 
PVDF membrane (Boehringer GmbH, Germany), stained 
[coomassie Blue R250 in 40% methanol (v/v)], destained 
with 50% methanol (v/v), rinsed with distilled water, and 
excised bands were supplied for N-terminal sequencing 
to Cambridge Biosciences. For LC–MS analysis, proteins 
in excised gel bands were digested with chymotrypsin or 
GluC proteases. LC–MS analysis was performed with 
a Sciex TripleTOF 6600 mass spectrometer coupled to 
an ekspert™ nanoLC 425 with low micro-gradient flow 
module (Eksigent) via a DuoSpray source (Sciex). Pep-
tides were separated on a C18 reverse phase column using 
a gradient of acetonitrile in 0.1% formic acid. MS–MS 
acquisition used precursor-ion scans (400 to 1600 m/z) 
of 250 ms followed by CID-fragmentation of up to ten 
multiply charged ions, with an MS/MS spectrum (m/z 
100–1600) acquisition time of 50 ms for each selected ion. 
MS-Analyst software version 1.7.1 (SCIEX) was used to 
acquire all MS and MS/MS data, MSConvert (ProteoWiz-
ard software suite) was used to generate peak lists and 
protein identification used Peaks Studio 8.5 in conjunction 
with a database containing known proteomic-experiment 
contaminants and the expressed proteins reported here.
Injection assays
Aethina tumida
Wandering (10–14 day old) A. tumida larvae were injected 
with 0 to 17.5 µg of protein (in 20 mM sodium phosphate 
buffer pH 7.4) using a Hamilton micro-syringe. Range-
finding experiments were conducted to establish appropri-
ate doses for  LD50 analysis, after which 4–5 different doses 
(ten larvae per dose; average wt. 18 mg) of each protein 
were injected. Larvae were anaesthetized using  CO2 and 
1 μl injected into the third dorsal segment; needles were 
left in the larvae for 30 s prior to withdrawal to reduce the 
expulsion of fluid from the wound. Larvae were placed in 
petri dishes lined with moist filter paper, and survival was 
monitored daily for 7 days.
Mamestra brassicae
Newly eclosed fifth stadium M. brassicae larvae (average wt. 
60 mg) were anaesthetized with  CO2 and injected with 5 μl 
of protein-containing solutions behind the head capsule as 
described for A. tumida. Larvae were placed in plastic pots 
lined with moist filter paper and containing artificial diet 
(A.D.), and survival was monitored daily for 7 days.
Apis mellifera
Newly emerged A. mellifera workers were anaesthetized by 
cooling on ice and injected using a Hamilton micro-syringe 
under the fifth abdominal segment with 2 μl containing 
10 µg Hv1a, or 40 µg of GNA or GNA/Hv1a (in sodium 
phosphate buffer). Controls were injected with sodium phos-
phate buffer alone. Adult honeybees (n = 20 per treatment; 
average wt. 100 mg) were supplied with 50% (w/v) sucrose 
solution and placed in an environmental chamber (night 
cycle, 34 °C, 60% R.H.). Survival was monitored daily for 
7 days.
Feeding assays
Aethina tumida larval “drinking assay”
Five-day-old larvae (n = 10 per treatment) were placed in 
plastic pots containing moist filter paper and two 1.5-ml 
eppendorf tube lids, each containing protein re-suspended 
in 75 μl buffer/sucrose (13% w/v) solutions. The liquid diet 
was changed every 24 h for 72 h, after which larvae were 
supplied with A.D. [1 ml of 50% (v/w) aqueous honey solu-
tion + 2.5 g crushed bee pollen] until they entered the wan-
dering stage (approx. 4 days post liquid feed). Mortality was 
recorded daily for 7 days.
Aethina tumida adult “drinking assay”
Adults (1 week old) were transferred into a 50-ml collection 
chamber containing two 1.5-ml eppendorf tube lids, each 
containing proteins re-suspended in 75 µl of buffer/sucrose 
(13% v/w) solution. The diet was changed every 48 h for 
6 days, after which adults were supplied with 50% honey 
solution until day 14.
Aethina tumida larval “brood assay”
To obtain egg counts, A. tumida egg slides were photographed, 
enlarged on computer and individual eggs counted. Slides 
containing 290–470 eggs were placed onto honeybee brood 
(4 cm × 3 cm × depth 3 cm) for 24 h. Slides were then removed, 
and the brood was sprayed with 1 ml of GNA/Hv1a at a con-
centration of 5 mg/ml or buffer only as a control. Brood pieces 
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were sprayed (Boots 100 ml travel spray bottle) every 24 h 
for 72 h after which larvae were supplied with brood ad libi-
tum until they entered the wandering stage when the number 
of surviving larvae was recorded. During the assay, live and 
dead larvae displaying a paralytic phenotype were collected for 
western analysis. Protein extracts were prepared from whole 
insects (pre-rinsed in dist. water) by re-suspension in sodium 
phosphate buffer (three larvae in 50 µl) homogenized using a 
sterile pestle and assayed for protein content using a Coomas-
sie Plus (Bradford) Assay Kit using bovine serum albumin as 
standard.
Stability studies
In vivo: Aethina tumida “larval dipping” assay
Five-day-old larvae (n = 10 per treatment) were soaked at 
room temperature (RT) in buffer/sucrose solutions containing 
2.5 mg/ml of GNA/Hv1a or Hv1a/GNA (controls were protein 
only no larvae), from which 5 μl samples were taken at speci-
fied time points for western analysis. Samples were boiled for 
10 min, centrifuged (5 min, 14,000g) and supernatants stored 
at − 80 °C until use.
In vitro: stability of fusion proteins incubated with Aethina 
tumida larval gut extracts
Feeding-stage larval gut samples were re-suspended in sodium 
phosphate buffer (10 guts in 200 μl), homogenized using a 
sterile pestle, centrifuged (5 min at 14,000g), and supernatants 
containing soluble gut proteins were assayed for protein con-
tent using a Coomassie Plus (Bradford) Assay Kit using bovine 
serum albumin as standard. The equivalent of two larval guts 
(40 µl) was incubated with 75 µg of GNA/Hv1a or Hv1a/GNA 
at RT and 5 μl samples taken at specified time points. Samples 
were prepared and stored as described previously.
Statistical analysis
All survival data were analysed using Kaplan–Meier survival 
analysis. Median lethal doses  (LD50 for injections and  LC50 for 
feeding experiments) were calculated by plotting log dose ver-
sus probit of corrected mortalities. Wandering larvae survival 
after brood assay experiments was analysed by Chi-square test 
for significant differences between single values. All statistical 
tests were carried out using GraphPad Prism software.
Results
Recombinant protein production in the yeast Pichia 
pastoris
Four constructs (Fig. 1a), all of which contain a six-resi-
due histidine tag to enable single-step affinity purification, 
were generated for expression of Hv1a/GNA, GNA/Hv1a, 
Hv1a toxin alone and GNA as recombinant proteins in 
transformed P. pastoris cells, using a benchtop fermenta-
tion system to produce sufficient quantities of proteins for 
bioassays. Analysis of affinity purified Hv1a/GNA, GNA/
Hv1a, GNA and Hv1a by gel electrophoresis is presented 
in Fig. 1b.
For Hv1a/GNA, a major protein of approx. 21 kDa and 
two closely separated proteins of approx. 14 kDa were 
present in purified samples (Fig. 1b); all three proteins 
reacted positively with anti-GNA and anti-His antibodies 
(Fig. 1c). The 21 kDa protein was confirmed by N-terminal 
sequencing to contain an additional five residues (Glu-Ala-
Glu-Ala-Ala, after removal of the yeast pre-pro-sequence) 
preceding the Hv1a peptide. Additional residues Glu-Ala-
Glu-Ala remain in expressed products due to incomplete 
processing of the alpha factor sequence by yeast dipepti-
dyl aminopeptidase, and the additional alanine is a conse-
quence of gene insertion via a Pst I restriction site. N-ter-
minal sequencing of the two 14 kDa proteins confirmed 
that these did not contain functional toxin, since cleavage 
of Hv1a/GNA had occurred at residues 25 and 36 of the 
Hv1a peptide, leaving only a partial toxin sequence fused 
to GNA. Thus, only the 21 kDa intact Hv1a/GNA protein 
was considered when assessing active fusion protein con-
tent in lyophilized samples.
For GNA/Hv1a, two proteins of approx. 20 and 19 kDa 
were apparent in purified fractions (Fig. 1b) and both pro-
teins reacted positively with anti-His antibodies (Fig. 1c), 
confirming that the N-terminus is intact in the expressed 
products. Analysis of gel slices by LC–MS confirmed (as 
for Hv1a/GNA) the presence of additional N-terminal resi-
dues (Glu-Ala-Glu-Ala-Ala) preceding the histidine tag 
sequence. Similarly to Hv1a/GNA, cleavage at residue 25 
of the Hv1a peptide was confirmed by LC–MS analyses 
of the 19 kDa band, showing this is a GNA/Hv1a cleavage 
product. Predicted and experimentally determined protein 
sequence data and representative mass spectra are pre-
sented in Online Resource 1(a–c). Thus, only the 20 kDa 
GNA/Hv1a protein was considered when assessing active 
fusion protein content in lyophilized samples.
Recombinant GNA runs as a single band of approx. 
14 kDa on SDS-PAGE gels, close to the predicted mass 
of 12.80 kDa, and reacts positively with anti-GNA and 
anti-His antibodies (Fig.  1c). As evident in Fig.  1b, 
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recombinant Hv1a does not separate well by gel electro-
phoresis, running as a smear on Tris-Tricine gels. This is 
indicative of poor binding of SDS to Hv1a and heavy gly-
cosylation. The predicted mass of Hv1a following removal 
of the pro-region is 6.75 kDa. A protein band of approx. 
15 kDa that reacts positively with anti-His antibodies 
(Fig. 1c) is evident in purified fractions, and an N-terminal 
sequence of Ser-Pro-Thr-Cys-Ile-Pro obtained by Edman 
degradation sequencing verified removal of the pro-region 
in the expressed product. All recombinant proteins were 
expressed at levels of 30–100 mg/l in culture supernatants.
Biological activity of recombinant proteins
Injection toxicity
The biological activity of purified proteins was assessed 
by injection into A. tumida and M. brassicae larvae, and 
A. mellifera adults.  LD50 values are presented in Table 1. 
For beetle and cabbage looper larvae, mortality following 
injections of Hv1a/GNA or GNA/Hv1a was predominantly 
observed 24–72 h post-injection.  LD50s for A. tumida larvae 
were comparable for Hv1a/GNA and GNA/Hv1a (0.9 and 
1.5 nmoles/g larvae, respectively), suggesting that the ori-
entation of the Hv1a toxin relative to GNA in the expressed 
protein product does not significantly affect functionality 
of the Hv1a peptide.  LD50s for Hv1a/GNA or GNA/Hv1a 
against cabbage looper larvae were also similar (18.0 and 
21.5 nmoles/g larvae, respectively) but more than tenfold 
greater than A. tumida values.
Whilst A. tumida larvae showed signs of paralysis after 
injections of Hv1a alone, mortality was not observed until 
6 days after treatment and the observed  LD50 of 6.4 nmoles/g 
larvae is more than four-fold higher than the  LD50 values for 
fusion protein treatments. Mortality of cabbage looper larvae 
injected with Hv1a alone also occurred over a longer period 
(5 days post-injection) although  LD50s for Hv1a alone as 
compared to the fusion proteins were similar. No mortality 
was recorded for A. tumida or M. brassicae larvae following 
injections of GNA at doses up to 43 and 30 nmoles/insect, 
respectively.
Honeybee adult survival was not affected by the injec-
tion of Hv1a, Hv1a/GNA, GNA/Hv1a, or GNA at doses 
up to 20-fold higher than those required to cause mortality 
in A. tumida and M. brassicae larvae.
Oral toxicity of recombinant proteins to Aethina tumida 
larvae and adults
The effects of orally delivered fusion proteins on A. tumida 
were evaluated by feeding larvae or adults on solutions 
containing different concentrations of Hv1a/GNA or GNA/
Hv1a, using GNA, Hv1a and no added protein as controls. 
Solutions were supplied for a limited period (3 days for 
larvae and 6 days for adults), after which insects were 
allowed access to control diet. As shown in Fig. 2, sig-
nificant dose-dependent reductions in survival of larval 
and adult insects were observed following the ingestion 
of either Hv1a/GNA or GNA/Hv1a, with mortality > 90% 
at the highest doses. Insects fed on Hv1a alone showed 
comparable survival to the control treatments. GNA fed 
to larvae at the highest concentration of 5 mg/ml caused 
a reduction in survival of up to 25%, as compared to the 
control diet-only treatment (P < 0.05; Mantel–Cox log-
rank test), whereas no reduction in survival was observed 
for GNA-fed adults.
GNA/Hv1a was more effective as a toxin towards A. 
tumida larvae than Hv1a/GNA. Feeding Hv1a/GNA 
caused a slower and lesser reduction in survival than 
GNA/Hv1a, resulting in a significant > twofold higher 
 LC50 value of 1.14 mg/ml for Hv1a/GNA as compared 
to 0.52 mg/ml for GNA/Hv1a. After 2 days of feeding at 
the higher GNA/Hv1a doses of 5.0 and 2.5 mg/ml, larvae 
exhibited impaired mobility and a “writhing” phenotype 
indicative of paralysis; this coincided with the onset of 
mortality, which even after transfer to control diet, contin-
ued to rise, reaching 100% after 7 days. Western analysis 
of haemolymph samples from larvae fed on fusion pro-
tein or GNA provided evidence for the ability of GNA 
to deliver Hv1a to the circulatory system of A. tumida 
(Online Resource 2).
Table 1  LD50 values (nmoles/g 
larvae) calculated from survival 
of A. tumida and M. brassica 
larvae (five doses, n = 10 per 
dose), and survival (%) of adult 
honeybee (A. mellifera; n = 20 
per treatment) after injection of 
recombinant proteins
Confidence intervals (95%) are provided in parenthesis
Treatment A. tumida  LD50 (day 7) M. brassica  LD50 (day 5) A. mellifera injection 
doses (nmoles/g adult 
bee)
A. mellifera 
survival (%)
Hv1a 6.4 (3.3–11.9) 18.1 (16.4–19.8) 148 100
GNA – – 312 95
Hv1a/GNA 0.9 (0.7–1.1) 18.0 (15.4–20.9) 228 95
GNA/Hv1a 1.5 (1.5–1.5) 21.5 (19.1–22.2) 231 90
Control – – 0 100
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Aethina tumida larval “brood assay”
GNA/Hv1a was selected for use in an experiment designed 
to mimic an “in-hive” application of a recombinant pro-
tein-based biopesticide. Aethina tumida egg slides were 
placed onto honeybee brood which was subsequently 
sprayed with GNA/Hv1a at a concentration of 5 mg/ml. 
As shown in Fig. 3a, visual evidence of the ability of A. 
tumida larvae to destroy honeybee brood within 4 days of 
egg hatch was apparent in the control treatment, whereas 
fusion protein-treated brood remained relatively intact and 
dead larvae surrounding the brood piece were clearly vis-
ible. Survival of larvae assessed at the wandering stage 
(i.e. approx. 10 days after the final spray application when 
larvae cease to feed) was 90–96% for controls, whereas 
significant levels of mortality (43–76%) were recorded 
for larvae reared on GNA/Hv1a-treated brood (Fig. 3b; 
P < 0.0001; Chi-square test). Western analysis of larval 
extracts (Fig. 3c) shows the presence of a single immuno-
reactive protein band corresponding in mass to GNA, in 
samples from dead larvae and larvae displaying a paralytic 
phenotype, but not live larvae. Spraying honeybee brood 
with protein solution offers the possibility of delivery of 
the Hv1a toxin to the CNS through contact (via cuticular 
spiracles) and ingestion, and this result confirmed that pro-
tein delivery was responsible for the observed mortality.
(a)
(b)
Fig. 2  Survival of A. tumida: a larvae and b adults fed on sucrose 
solutions containing 5  mg/ml GNA, 1.25  mg/ml Hv1a or 0.312–
5.0  mg/ml of (i) Hv1a/GNA or (ii) GNA/Hv1a. Controls were fed 
on sucrose/sodium phosphate buffer. N = 20 per treatment. Asterisks 
depict significant differences to controls (***P < 0.0001, **P < 0.001, 
*P < 0.05; Mantel–Cox log-rank test). Grey shading depicts fusion 
protein treatment duration;  LD50 confidence intervals (95%) for  LD50 
values are provided in parenthesis
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Aethina tumida larval gut proteases and fusion protein 
stability in vivo and in vitro
Two approaches were taken to examine whether variabil-
ity in the efficacy of Hv1a/GNA and GNA/Hv1a towards 
larvae was related to differences in the stability of the 
fusion proteins to proteolytic cleavage. Firstly, larvae 
were soaked in fusion protein solutions, thereby exposing 
the proteins to extracellular proteases in the gut, regur-
gitant and/or frass. As shown in Fig. 4a, differences in 
the susceptibility of GNA/Hv1a and Hv1a/GNA to pro-
teolytic degradation were evidenced by the disappearance 
of immunoreactive bands corresponding in mass to intact 
fusion protein over a sampling period of 24 h. For Hv1a/
GNA, samples taken after just 1 h of incubation contained 
a single immunoreactive band corresponding in mass to 
GNA alone, indicating that the Hv1a peptide was rapidly 
cleaved in vivo. By contrast, intact GNA/Hv1a was pre-
sent in samples incubated with larvae for up to 8 h, with 
complete cleavage of the Hv1a peptide from the fusion 
protein to yield GNA alone evident in the 24 h sample. 
Western analysis of fusion protein samples incubated in 
the presence of larval gut extracts (Fig. 4b) gave com-
parable results to in vivo experiments providing further 
evidence that GNA/Hv1a is more resistant to proteolytic 
degradation than Hv1a/GNA.
Larval gut proteolytic activity was analysed by zymog-
raphy, and major protease classes were characterized using 
protease inhibitors. Results suggested trypsin-like serine 
proteases that are sensitive to both soybean Kunitz trypsin 
inhibitor (SKTI) and soybean Bowman–Birk inhibitor 
(SBBI) are dominant in A. tumida larval guts (results not 
shown). Subsequently, Hv1a/GNA and GNA/Hv1a were 
both shown to be resistant to cleavage when incubated 
for 24 h with larval gut extracts in the presence of SKTI, 
indicating that trypsin proteolysis was responsible for the 
observed cleavage of fusion proteins.
Fig. 3  a Damage to bee brood 
caused by feeding A. tumida lar-
vae in (i) control brood sprayed 
with sodium phosphate solution, 
(ii) brood sprayed with GNA/
Hv1a (1 ml of 5 mg/ml FP solu-
tion every 24 h for 72 h). Photo-
graphic image taken 72 h after 
the onset of the assay. Arrows 
indicate dead larvae. b Survival 
of larvae (at the wandering 
stage) after application of egg 
slides to bee brood treated with 
GNA/Hv1a (5 mg/ml in sodium 
phosphate buffer) or control 
(buffer only) solution. N = 3 
per treatment. Asterisks depict 
significant difference to the 
control treatment (P < 0.0001; 
Chi-square test). c Western 
analysis (anti-GNA antibod-
ies) of larvae fed on GNA/
Hvla-treated bee brood. Extracts 
(40 µg total protein) prepared 
from whole dead larvae (D, lane 
1); larvae displaying a “writh-
ing” phenotype (W, lane 2) and 
live (L, lane 3) larvae. Lanes 4 
and 5 are, respectively, 100 ng 
of GNA/Hv1a and recombinant 
GNA
(a)
(b) (c)
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Discussion
The purpose of this study was to evaluate the potential use of 
recombinant fusion proteins comprised of the spider venom 
peptide neurotoxin Hv1a fused to the carrier protein GNA, 
as a novel and target-specific method to control A. tumida. 
The specificity of the toxin has been confirmed by injection 
assays reported here, which show that Hv1a (alone and when 
fused with GNA) caused high levels of A. tumida larval mor-
tality at nanomolar concentrations, whereas no detrimen-
tal effects on honeybees were observed. However, feeding 
assays with larval and adult beetles show that Hv1a alone 
is ineffective orally and that fusion to the delivery protein 
GNA is necessary to achieve ingestion toxicity of the fusion 
proteins. Finally, experiments designed to simulate an “in-
hive” application of a fusion protein product demonstrated 
mortality of A. tumida larvae, providing proof of concept 
for the potential use of fusion protein-based biopesticides to 
control this invasive pest of the European honey bee.
Hv1a, when tested in native form or as a synthetic or 
recombinant protein product, has previously been shown to 
be toxic by injection into a wide range of insects (Fletcher 
et al. 1997; Tedford et al. 2004b; Bloomquist 2003; Mukher-
jee et al. 2006). Doses required to induce paralysis and/
or mortality are highly variable, ranging from an  LD50 of 
9.4 pmol/g adult fruit fly (Drosophila melanogaster) (Guo 
et al. 2018) to an  ED50 of 3 nmol/g larvae of the cotton 
bollworm (Heliothis armigera) (Atkinson et al. 1998). Vari-
ability in injection efficacy reflects variation in the ability of 
the toxin to disrupt ion channel function in different insects 
as well as the use of different sources of peptides and ease 
of injection. Here, we report an  LD50 of 6.4 nmol Hv1a/g A. 
tumida, for recombinant Hv1a produced using yeast, dem-
onstrating that the toxin disrupts ion channel function in 
coleopteran larvae. That Hv1a is a more efficacious towards 
A. tumida as compared to M. brassicae is indicated by the 
three-fold higher injection  LD50 (18 nmol Hv1a/g insect) 
obtained for M. brassicae larvae. Injection toxicity towards 
M. brassicae larvae was comparable to previous results 
obtained for recombinant Hv1a produced using bacteria 
(Fitches et al. 2012), suggesting both expression hosts are 
capable of producing similar levels of correctly folded and 
functional toxin.
Injections of GNA/Hv1a or Hv1a/GNA into M. brassicae 
larvae resulted in similar levels of mortality compared to 
Hv1a alone and were comparable to previously published 
data for Hv1a/GNA (Fitches et al. 2012). By contrast, A. 
tumida were far more susceptible to injected GNA/Hv1a 
or Hv1a/GNA where mortality occurred more rapidly and 
 LD50s were four-fold lower as compared to Hv1a alone. The 
reasons for this are not entirely clear but given previous evi-
dence for the binding of GNA and Hv1a/GNA to the central 
(a)
(b)
Fig. 4  Stability of fusion proteins to degradation by A. tumida larval 
proteases a Western blot analysis of solutions [2.5  mg fusion pro-
tein (FP)/ml] in which larvae had been immersed for specified time 
points. C denotes control FP sample alone (no larvae) incubated at 
RT for 24 h. b Western blot analysis of FP samples following incuba-
tion with larval gut extracts; 75 µg FP + 40 µl gut extract. For each 
time point, 300  ng FP loaded. C1 denotes control FP alone, C2 is 
FP + boiled gut extract, both incubated at RT for 24 h. GNA denotes 
100 ng recombinant GNA standard
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nerve chord of M. brassicae larvae, the greater efficacy and 
more rapid onset of mortality in fusion protein-injected A. 
tumida observed here may reflect the ability of GNA to 
“deliver” the Hv1a toxin from the circulatory system to the 
CNS (Fitches et al. 2012). It is also possible that fusion to 
GNA renders the Hv1a toxin less susceptible to degradation 
in the haemolymph.
Here, we provide further evidence of the ability of GNA 
to potentiate the oral toxicity of spider venom peptides as 
GNA/Hv1a and Hv1a/GNA, when delivered orally, caused 
dose-dependent reductions in the survival of A. tumida lar-
vae and adults, whereas no impact on survival was found 
for insects fed on Hv1a alone. However, we also show that 
the orientation of the toxin relative to the carrier GNA has a 
considerable impact upon efficacy towards A. tumida. Larvae 
and adults were more susceptible to ingested GNA/Hv1a as 
compared to Hv1a/GNA with differences in efficacy most 
apparent in larvae, where an  LC50 of 0.52 mg/ml for GNA/
Hv1a was significantly lower (by approx. two-fold) than 
that obtained for Hv1a/GNA. GNA/Hv1a was subsequently 
shown to be more resistant to degradation by A. tumida 
gut proteases as compared to Hv1a/GNA. We suggest that 
the reduced susceptibility of GNA/Hv1a to degradation by 
gut proteases would enable larger amounts of toxin to be 
delivered to the haemolymph and CNS, thereby resulting in 
enhanced toxic effects.
Whilst Hv1a/GNA and GNA/Hv1a contain identical 
proteolytic cleavage sites, the susceptibility of these sites 
to proteolysis is presumably determined by how exposed 
or protected vulnerable sites are to proteases in the tertiary 
structure of the chimeric protein. Expression of Hv1a/
GNA in yeast yields intact fusion protein and two cleavage 
products; N-terminal sequencing confirmed that full-length 
Hv1a/GNA is susceptible to cleavage during expression at 
two sites located at the C-terminus of Hv1a. That Hv1a/
GNA is prone to proteolysis at the C-terminus of Hv1a 
within the insect gut was shown by the rapid appearance 
of immunoreactive proteins corresponding in mass to GNA 
alone in samples exposed to A. tumida gut proteases (Fig. 4a, 
b). By comparison, the expression of GNA/Hv1a in yeast 
yields two products. Western blot and LC–MS peptide 
mass analysis shows that the larger mass protein is intact 
fusion protein and the smaller product has been cleaved, as 
in Hv1a/GNA, at residue 25 at the C-terminus of Hv1a pep-
tide. Characterization of recombinantly expressed proteins 
together with susceptibility to proteolysis in the insect gut 
collectively suggests that the C-terminus of Hv1a is more 
exposed to both yeast and insect proteases when the peptide 
is linked to the N-, rather than the C-terminus of GNA.
In experiments designed to simulate an “in-hive” appli-
cation of a fusion protein product, we observed significant 
levels of A. tumida larval mortality following the treatment 
of brood pieces sprayed with GNA/Hv1a over a period of 
72 h. In these experiments, it is possible that the fusion 
protein exerts both contact (via entry through spiracles) 
and ingestion activity. Indeed, western analysis confirmed 
that mortality and the observed paralytic phenotype were 
attributable to ingestion and/or cuticular penetration of 
the fusion protein. As GNA/Hv1a was only tested at a 
dose of 5000 ppm, dose–response studies are required to 
determine the most appropriate practical application rate. 
Additional experiments are also needed to understand how 
persistent the effects of GNA/Hv1a are as this would help 
to determine how much and how often hives should be 
sprayed to ensure effective control of A. tumida-infested 
hives. It is further anticipated that GNA/Hv1a efficacy 
and persistence may both be enhanced through formula-
tion. The absence of Hv1a toxicity towards honeybees 
observed in this study, even when the peptide or GNA 
fusion proteins were injected at more than 20-fold higher 
doses than those required to cause significant A. tumida 
larval mortality, is in agreement with results obtained by 
Nakasu et al. (2014 who reported that Hv1a/GNA shows 
no contact (adult) or acute oral (adults and larvae) toxic-
ity towards honeybees exposed to 100 μg fusion protein/
bee. Nevertheless, chronic toxicity studies are required to 
establish if there are likely to be any detrimental effects 
upon honeybee adults and/or larvae exposed to GNA/Hv1a 
via the repeated spraying of infested hives.
Significant levels of adult A. tumida mortality observed 
following feeding on sucrose solutions containing GNA/
Hv1a also suggest the possibility of incorporating the 
fusion protein in a bait for the control of adults as they 
enter hives. A number of traps (in and outside hives) are 
currently used where beetle refuges are filled with control 
products such as oil, veterinary medicine or a mix of yeast 
pollen and brood (Neumann et al. 2016). It is likely that 
GNA/Hv1a would be prone to fairly rapid degradation in 
the presence of an enzyme-rich brood-based bait rendering 
it ineffective. Further studies to identify whether GNA/
Hv1a could be combined with other bait ingredients or to 
develop a new fusion protein bait formulation are required. 
However, efficacious control of adult beetles via trapping 
is unlikely to be achieved until an effective lure that is 
more attractive to A. tumida than honeybees is developed.
Current measures for A. tumida are multifaceted, 
requiring a combination of all available control meth-
ods (mechanical, biological and chemical). The results 
reported here indicate that fusion protein-based biopesti-
cides could offer the opportunity to reduce reliance upon 
broad-spectrum chemicals whilst also being compatible 
with an integrated pest management approach to control 
this serious invasive pest of honeybees.
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